Alnylam Pharmaceuticals
ALNY
#542
Rank
HK$349.06 B
Marketcap
HK$2,642
Share price
0.07%
Change (1 day)
23.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company